findmyKOL

Teresa Diaz-Montes, MD, MHS

Basic profile

Greater Baltimore Medical Center

ORCIDNPI
RegionBaltimore, MD · NortheastSpecialtyGynecologic OncologyFocusOncology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Teresa Diaz-Montes is an Oncology physician affiliated with Greater Baltimore Medical Center. OpenAlex indexes 197 publications with 1,832 citations (h-index 25); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
197publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,832citations

Total citations across indexed works.

25h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

227 St. Paul Place
6th Floor
Baltimore, MD 21202

Telephone

410-332-9200

Registry record last updated 10 Dec 2013.

View the NPPES registry record

Clinical trials

1 registered study on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Genitourinary & hormones

    47.1%
    Estrogen47.1%
    Estradiol100%
    Part D26 patients
  • Sensory organs

    42%
    Corticosteroid32.8%
    Clobetasol Propionate69%Hydrocortisone31%
    Part D<11 patients
    Fluoroquinolone Antibacterial9.2%
    Ciprofloxacin Hcl100%
    Part D<11 patients
  • Anti-infectives

    10.9%
    Azole Antifungal10.9%
    Fluconazole100%
    Part D11 patients
Where care is delivered (Part B)35.3% facility · 64.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”